This announcement is a separate document:
基石藥業-B：(1)截至二零二二年六月三十日止六個月中期業績公告；(2)本公司首席執行官、執行董事、戰略委員會主席及授權代表停任；及(3)委任本公司首席執行官、執行董事、戰略委員會主席及授權代表
CSTONE PHARMA-B: (1) ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022; (2) CESSATION TO ACT AS THE CHIEF EXECUTIVE OFFICER, THE EXECUTIVE DIRECTOR, THE CHAIRMAN OF THE STRATEGY COMMITTEE AND AN AUTHORIZED REPRESENTATIVE; AND (3) APPOI
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.